tirzepatide brand name Eli Lilly targets FDA approval for weight loss medication How Does Tirzepatide Success Work

The test ($99 add-on after your first treatment month) analyzes GLP1R, GIPR, MC4R, and 11 other genetic pathways to reveal how your body processes peptide signals

Most events included nausea, diarrhoea, and vomiting and were mild to moderate

Add the Precision Peptide Genetic Test ($99 after your first month) to confirm your personalized response profile and ensure optimal compound selection

Pricing confirmed at checkout reflects the final total

Tirzepatide Compounded Dual GLP-1/GIP Receptor Agonist A next-generation weight loss medication that targets two metabolic pathways, GLP-1 and GIP receptors, for enhanced appetite control, improved insulin sensitivity, and greater fat metabolism